(Approved by Department of Scientific & Industrial Research, (DSIR))
Kimia Biosciences R&D is committed to research and development of improved generic drugs with the goal of addressing unmet patient needs with more meticulous resources and to establish a robust portfolio for a new generation of treatments. Kimia is committed to do significant investments in drug research and development in order to produce effective, safe and affordable medicines.
Kimia R&D has well equipped Analytical Lab, synthetic Lab and Intellectual property cell, where each scientist has access to Sci-finder search tools. The Analytical Research lab comprises of HPLC, GC, GC-HS, Auto-Titrator, Polarimeter, UV spectrophotometer, IR spectrophotometer etc. There are dedicated hoods for each scientist in the synthetic lab with Rotavapours, Vacuum & Air dryers, cooling units, mechanical and magnetic stirrers, vacuum systems Instrumentation, scientific and analytical knowledge base at the R&D Centre facilitate:
The expertise of R&D teams covers products across various therapeutic categories including Ant diabetics & Anti-hypertensive.
We are committed to create a culture of respect and dignity of each individual based on humanistic values at Kimiabiosciences where the individuality of each person is respected
Kimia strives hard and give their best to help meet customer deadlines with ICH quality products; the average time todevelop a process technology is 6-8 months
TNo. of patent applications filed: 4
The team of Scientists at Kimia R&D involves people from diverse backgrounds who uses their vast experience & innovativeness and are determined to make Kimia R&D as an advance Centre for Research.
The Kimia R&D is committed to produce drugs of high quality based on principles of quality by design and ICH requirements